TecMed
2009-present (16 years)
TecMed, Inc., a privately held intellectual property (IP) company focused on non-invasive blood glucose management, specializes in IP which allows for increased accuracy, reliability and cost effectiveness in blood glucose measurement. The early designs incorporating our core technology and patented scientific principles have consistently demonstrated precision in measurement far superior to current measurement devices and technologies. Our core technology began as The Sentinel, a non-invasive consumer glucose measurement device. This technology led into the development and refinement of IP designed specifically for automated blood glucose measurement before, during and after surgical procedures and in critical care units. Research consistently shows that properly managed blood sugar reduces healthcare costs and improves patient outcomes. Today, there are no patient monitoring solutions that provide this data with sufficient accuracy, immediacy, or frequency to achieve necessary bloodSee more
Find 2 more new buyers similar to 
